TransMedics Group Inc. | Mid-cap | Healthcare
$134.01
1.95%
| TransMedics Stock Comparison:
TransMedics vs Abbott LaboratoriesTransMedics vs Boston ScientificTransMedics vs MasimoTransMedics vs Globus MedicalTransMedics vs Bio-RadTransMedics vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 441.5M
Gross Profit 262.1M 59.36%
Operating Income 37.5M 8.49%
Net Income 35.5M 8.03%
EPS (Diluted) $1.07

Balance Sheet Metrics

Total Assets 804.1M
Total Liabilities 575.5M
Shareholders Equity 228.6M
Debt to Equity 2.52

Cash Flow Metrics

Operating Cash Flow 46.4M
Free Cash Flow -80.9M

Revenue & Profitability Trend

TransMedics Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 441.5M 241.6M 93.5M 30.3M 25.6M
Cost of Goods Sold 179.5M 87.5M 28.2M 9.1M 9.0M
Gross Profit 262.1M 154.1M 65.3M 21.2M 16.6M
Operating Expenses 224.6M 182.8M 96.7M 60.6M 43.0M
Operating Income 37.5M -28.7M -31.4M -39.4M -26.4M
Pre-tax Income 35.8M -26.7M -36.2M -44.2M -28.7M
Income Tax 316.0K -1.6M 66.0K 36.0K 32.0K
Net Income 35.5M -25.0M -36.2M -44.2M -28.7M
EPS (Diluted) $1.07 -$0.77 -$1.23 -$1.60 -$1.16

Income Statement Trend

TransMedics Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 497.2M 510.7M 252.3M 118.7M 146.8M
Non-Current Assets 306.9M 195.4M 24.9M 16.2M 5.3M
Total Assets 804.1M 706.0M 277.1M 134.9M 152.0M
Liabilities
Current Liabilities 59.9M 54.9M 23.7M 23.2M 11.9M
Non-Current Liabilities 515.6M 513.9M 66.1M 43.8M 36.3M
Total Liabilities 575.5M 568.8M 89.8M 67.0M 48.1M
Equity
Total Shareholders Equity 228.6M 137.2M 187.4M 67.9M 103.9M

Balance Sheet Composition

TransMedics Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 35.5M -25.0M -36.2M -44.2M -28.7M
Operating Cash Flow 46.4M -24.8M -54.0M -32.9M -31.0M
Investing Activities
Capital Expenditures -129.7M -151.8M -11.9M -3.5M -455.0K
Investing Cash Flow -129.3M -166.7M 54.5M 29.3M -41.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 0 393.3M 162.3M 0 74.3M
Free Cash Flow -80.9M -192.1M -57.7M -32.4M -30.7M

Cash Flow Trend

TransMedics Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 89.81
Forward P/E 77.29
Price to Book 16.20
Price to Sales 8.84
PEG Ratio 77.29

Profitability Ratios

Profit Margin 10.03%
Operating Margin 19.12%
Return on Equity 22.99%
Return on Assets 4.21%

Financial Health

Current Ratio 9.10
Debt to Equity 194.67
Beta 2.08

Per Share Data

EPS (TTM) $1.42
Book Value per Share $7.87
Revenue per Share $14.59

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
tmdx 4.3B 89.81 16.20 22.99% 10.03% 194.67
Abbott Laboratories 231.9B 17.31 4.75 30.65% 31.89% 27.09
Boston Scientific 149.9B 73.94 6.75 9.50% 11.58% 52.16
Masimo 9.1B 129.16 9.63 -25.07% -23.25% 72.01
Globus Medical 7.8B 43.14 1.91 4.63% 7.39% 2.27
Bio-Rad 6.8B -3.83 1.03 -27.52% -85.16% 20.50

Financial data is updated regularly. All figures are in the company's reporting currency.